obesity drug news today glp-1 october 21 2025 Outlook for in 2025: more than a transition year GLP-1 Weight-Loss Drugs Ride Health,
Description
They activate GLP-1 receptors in your body, leading to an increase in the production of insulin, which helps move glucose into your cells, where its used for energy, Dr
This is all very hand-wavy theory right now, but could it be the insulin thats having some of these effects in the brain? It is clear that insulin dysregulation affects the brain, as evidenced by certain neurodegenerative diseases
Other therapies that target the incretin system cause GI discomfort and may worsen patient compliance
One company has already announced that it will stop manufacturing the doses of semaglutide that are available as Wegovy, but will continue to manufacture personalized doses
What is the risk profile of GLP-1 drugs
